STOCK TITAN

TARS (NASDAQ: TARS) files notice to sell 2,186 shares via Fidelity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

TARS submitted a Form 144 to sell 2,186 shares of Common stock. The notice lists Fidelity Brokerage Services LLC as broker with a sale date of 03/19/2026. The filing also shows a restricted stock vesting event on 03/18/2026 for 2,186 shares and prior reported sales of 2,111 and 2,133 on 03/17/2026

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does TARS's Form 144 report?

The filing reports a proposed sale of 2,186 shares of Common stock through Fidelity Brokerage Services LLC with a sale date of 03/19/2026. It also notes a restricted stock vesting on 03/18/2026 for the same share amount.

Who is listed as selling or holding the shares in the TARS Form 144?

The broker is listed as Fidelity Brokerage Services LLC. The filing shows prior transactions by Jeffrey Farrow with reported sales of 2,111 shares on 03/17/2026 and 2,133 shares on 03/18/2026.

Does the Form 144 show why the shares are being sold?

The filing links the 2,186 shares to a restricted stock vesting event dated 03/18/2026. No other economic rationale or use of proceeds is provided in the excerpt.

Are the sale dates and share counts specified in the TARS filing?

Yes. The excerpt lists a sale date of 03/19/2026 for 2,186 shares and prior reported sales of 2,111 and 2,133 on 03/17/2026 and 03/18/2026, respectively.

Does the Form 144 indicate the transaction method or broker?

Yes. The filing identifies Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield RI as the broker-dealer handling the proposed sale of 2,186 shares on 03/19/2026.
Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

View TARS Stock Overview

TARS Rankings

TARS Latest News

TARS Latest SEC Filings

TARS Stock Data

2.90B
40.38M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
IRVINE